Product Name | MF | CAS | Details |
---|
Duocarmycin analog-2 | C29H23ClN4O3 | 1164275-01-7 | Details |
10-Formyl-5,8-dideazafolic acid | C22H21N5O7 | 61038-31-1 | Details |
UNC4203 | C30H44N6O | 1818234-19-3 | Details |
Clevudine triphosphate | O10P3-5 | 174625-00-4 | Details |
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 486429-95-2 | Details |
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine | C41H36O2P2 | 301847-91-6 | Details |
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride | C14H16ClN7 | 2331268-15-4 | Details |
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate | C11H8BrNO3 | 377059-68-2 | Details |
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine | C42H38O2P2 | 301847-92-7 | Details |
Nrf2 activator-4 | C23H24ClF3N2O3 | 2383016-68-8 | Details |
NDB | C26H28Cl2N2O2 | 1660153-08-1 | Details |
Xanthine amine congener hydrochloride | C21H29ClN6O4 | 1783977-95-6 | Details |
Org 43553 | C24H30N6O3S2 | 501444-88-8 | Details |
SMO-IN-3 | C27H25F4N3O2 | 2376914-71-3 | Details |
PTP1B-IN-15 | C19H17Br2NO5S | 765317-71-3 | Details |
CCT369260 | C24H31ClF2N6O2 | 2647503-57-7 | Details |
Nezulcitinib | C30H37N7O2 | 2412496-23-0 | Details |
MK-8153 | C24H28N2O6 | 1548286-45-8 | Details |
BRL-15572 hydrochloride | C25H28Cl2N2O | 1173022-77-9 | Details |
IXA6 | C22H20ClN3O3S | 1021106-40-0 | Details |
Glyoxalase I inhibitor 2 | C24H23N3O4S | 2314467-61-1 | Details |
ZINC09659342 | C23H15F3N2O4 | 1668604-47-4 | Details |
PND-1186 hydrochloride | C25H27ClF3N5O3 | 1356154-94-3 | Details |
DG013A | C27H37N4O4P | 2007955-07-7 | Details |
Mytoxin B | C29H36O9 | 105049-15-8 | Details |
Glucametacine | C25H27ClN2O8 | 52443-21-7 | Details |
GSK2647544 | C24H18ClF3N4O3 | 1380426-95-8 | Details |
ONO-9780307 | C30H35NO7 | 856691-44-6 | Details |
CDK5-IN-2 | C29H28FN5O | 2639542-22-4 | Details |
PI3K/mTOR Inhibitor-4 | C27H22FN3O6S | 2361215-32-7 | Details |
Ifetroban sodium | C25H33N2NaO5 | 156715-37-6 | Details |
GNF2133 hydrochloride | 2561414-57-9 | Details |
Darglitazone Sodium | C23H20N2O4S.Na | 149904-87-0 | Details |
Regorafenib mesylate | C22H19ClF4N4O6S | 835621-08-4 | Details |
BSJ-01-175 | C30H33ClN6O2 | 2227392-55-2 | Details |
Tubulin inhibitor 23 | C26H23NO6S | 170488-57-0 | Details |
ITK inhibitor 6 | C28H24F2N4O2 | 2404604-06-2 | Details |
NF-κB/MAPK-IN-1 | C27H27NO7 | 2413940-56-2 | Details |
Tripelennamine citrate | C22H29N3O7 | 6138-56-3 | Details |
Laniquidar | C37H36N4O3 | 197509-46-9 | Details |
A2A receptor antagonist 3 | C26H26N6O2 | 2738606-83-0 | Details |
BS-181 dihydrochloride | C22H33ClN6 | 1883548-83-1 | Details |
TXA6101 | C18H10BrF5N2O3 | 1459695-66-9 | Details |
Efpeglenatide | 1296200-77-5 | Details |
CJ-2360 | C27H30FN5O2 | 2226742-61-4 | Details |
HAMI 3379 | C34H45NO8 | 1245653-57-9 | Details |
BMS-566419 | C28H30FN5O2 | 566161-24-8 | Details |
ABC44 | C31H40N6O5 | 1831135-46-6 | Details |
Edecesertib | C22H22FN7O2 | 2408839-73-4 | Details |
Vamotinib | C29H27F3N6O | 1416241-23-0 | Details |
RIPK3-IN-1 | C29H25FN4O4 | 2361139-70-8 | Details |
Tau-aggregation and neuroinflammation-IN-1 | C25H20N2O7 | 2175953-98-5 | Details |
CQ211 | C26H22F3N7O2 | 2648986-65-4 | Details |
CSF1R-IN-3 | C30H38N8O4 | 2760584-90-3 | Details |
Bafrekalant | C29H31ClN6O2 | 2256770-44-0 | Details |
MCT1-IN-3 | C22H19N3O4 | 2878360-80-4 | Details |
Ezurpimtrostat hydrochloride | C25H32Cl2N4 | 1914148-73-4 | Details |
Sipagladenant | C20H19N3O4S | 858979-50-7 | Details |
Tubulin inhibitor 18 | C22H26O5 | 2762382-51-2 | Details |
BRD3731 | C24H31N3O | 2056262-07-6 | Details |
CC214-2 | C20H25N5O3 | 1228012-18-7 | Details |
OTS964 | C23H24N2O2S | 1338542-14-5 | Details |
Claficapavir | C17H12ClNO4S2 | 2055732-24-4 | Details |
S 17092 | C22H28N2O2S | 176797-26-5 | Details |
GSK2646264 | C24H26N2O2 | 1398695-47-0 | Details |
XT2 | C19H14FN5OS | 2582816-37-1 | Details |
CB1/2 agonist 3 | C25H41NO2 | 2772655-86-2 | Details |
SARS-CoV-2 nsp13-IN-1 | C27H20N4O2 | 1005304-44-8 | Details |
AGN 192870 | C27H22O2 | 166977-57-7 | Details |
BACE-IN-1 | C22H16ClN5O2 | 1254166-60-3 | Details |
Sulfinalol | C20H27NO4S | 66264-77-5 | Details |
Epitinib | C24H26N6O2 | 1203902-67-3 | Details |
BI-10 | C23H17BrN2O | 2759037-58-4 | Details |
Aspochalasin M | C24H35NO4 | 1173040-34-0 | Details |
HIV-1 inhibitor-31 | C21H13Cl2N3O2 | 920036-04-0 | Details |
GRK6-IN-2 | C21H21FN6 | 2677786-27-3 | Details |
IAA65 | 2987139-96-6 | Details |
Penamecillin | C19H22N2O6S | 983-85-7 | Details |
IM-93 | C21H28N4O2 | 1173657-73-2 | Details |
ML138 | C19H14Cl2N4OS | 1355243-24-1 | Details |
BMT-090605 hydrochloride | C21H25ClN4O2 | 2231664-45-0 | Details |
Ro 363 hydrochloride | C19H26ClNO6 | 250580-70-2 | Details |
Sovesudil | C23H22FN3O3 | 1333400-14-8 | Details |
HTT-D3 | C23H25FN6 | 2254502-89-9 | Details |
DS-6930 | C23H21N3O4 | 1242328-82-0 | Details |
Quinine hydrobromide | C20H25BrN2O2 | 549-49-5 | Details |
DDO-02005 | C21H26ClN3O2 | 1186049-44-4 | Details |
ST247 | C19H26N2O5S2 | 1356497-91-0 | Details |
18-Deoxyherboxidiene | C25H42O5 | 1200128-66-0 | Details |
Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
EHT 5372 | C17H11Cl2N5OS | 1425945-63-6 | Details |
CB1R antagonist 1 | C18H23F3N2O3S | 334668-69-8 | Details |
Neldazosin | C18H25N5O4 | 109713-79-3 | Details |
DSS30 | C16H14ClNO3S2 | 883027-32-5 | Details |
PI3K-IN-38 | C20H24N6O2 | 1382979-64-7 | Details |
WIN 54954 | C18H20Cl2N2O3 | 107355-45-3 | Details |
Pixantrone hydrochloride | C17H20ClN5O2 | 175989-38-5 | Details |
Bromodomain inhibitor-10 | C20H20N4O3 | 1870849-58-3 | Details |
BCR-ABL1-IN-1 | C18H12F3N3O2 | 1488090-21-6 | Details |
BRD-8899 | C17H22N4O3S | 1404437-50-8 | Details |
Product Total: Product Page: | ||||
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 |